Boehringer Ingelheim Investigational Site

Reno, Nevada 89502-1196

0 studies enrolling now · 3 studies all time

What they study most

Arthritis, Rheumatoid, Pulmonary Disease, Chronic Obstructive

Studies at this site

• A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis — Completed
• Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• High Dose Trial in COPD — Completed